Kontakte:Errol Zhou (Mesye.)
Tel: plis 86-551-65523315
Mobile/WhatsApp: plis 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Imèl:sales@homesunshinepharma.com
Ajoute:1002, Huanmao Bilding, No.105, Mengcheng Wout, Hefei Vil, 230061, Lachin
CAS NON: 1216941-48-8
Fòmil molekilè: C40H43N7O7S
Pwa molekilè: 765.87700
EINECS NON: NA
MDL NON: NA
Deskripsyon pwodwi:
Non pwodwi: Paritaprevir (ABT-450) CAS NO: 1216941-48-8
Sinonim:
(2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-(5-methylpyrazin-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1, 2,3,6,7,8,9,10,11,13a,14,15,16,16atetradecahydrocyclopropa(E)pyrrolo(1,2-a)(1,4)diazacyclopentadecine-14a(5H)-carboxamide;
Veruprevir anidrid;
Chimik& Pwopriyete fizik:
Aparans: solid oswa likid
Esè: ≥99.0%
Dansite: 1.45±0.1 g / cm3 (Prevwa)
Paritaprevir (ABT-450) se yon pisan pwoteyin ki pa estriktirèl 3/4A (NS3/4A) inibitè proteaz ak EC50s nan 1 ak 0.21 nM kont HCV 1a ak 1b, respektivman.
Si w enterese nan pwodwi nou yo oswa si w gen nenpòt kesyon, tanpri ou lib pou kontakte nou!
Pwodwi anba patant yo ofri pou R& D objektif sèlman. Sepandan, responsablite final la se sèlman nan achtè a.
Baj popilè: paritaprevir (abt-450) cas 1216941-48-8, manifaktirè, founisè, faktori, achte, nan stock